Giuseppe M.
- Country
- Italy
- Department
- Dip. Scienze Radiologiche, Radioterapiche ed Oncologiche
Research Overview
- "APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIAN".
- Phase II Multicenter Randomized Study of Regorafenib in Recurrent Grade 2 and 3 Meningioma Post-Surgery and Radiotherapy
- Phase III Randomized Study of Lomustine With or Without Reirradiation in First Progression of Glioblastoma
Data & Insights
Has run more than one trial at 19 of 81 partner sites.
Specializations
Neuro-Oncology
The investigator specializes in treating high-grade meningiomas, with particular focus on managing grade 2 and grade 3 meningiomas that have progressed after initial treatments. Their research extends to exploring novel therapeutic approaches for patients who have exhausted standard treatment options.
- Progressive Meningioma Management
- Post-surgical Recurrence
- Advanced Treatment Protocols
Glioblastoma Treatment
The investigator focuses on developing treatment strategies for newly-diagnosed glioblastoma and its recurrence. Their expertise includes managing MGMT unmethylated glioblastoma and exploring innovative therapeutic combinations including radiation therapy approaches.
- Primary Glioblastoma Treatment
- Recurrent Disease Management
- Combined Modality Therapy
Genitourinary Oncology
The investigator has developed expertise in treating metastatic hormone-sensitive prostate cancer, with particular interest in oligometastatic disease. Their work encompasses integrated treatment approaches combining systemic therapies with targeted radiation treatments.
- Oligometastatic Disease Management
- Hormone-Sensitive Disease
- Multimodal Treatment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.